| Cancer of the cervix uteri |
119 |
| The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention |
53 |
| Update on the diagnosis and management of gestational trophoblastic disease |
49 |
| The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions |
45 |
| Cancer of the corpus uteri |
44 |
| Cancer of the ovary, fallopian tube, and peritoneum |
33 |
| FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders |
31 |
| A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception |
19 |
| Conservative management of placenta percreta |
15 |
| Cancer of the vulva |
15 |
| Systematic review and meta-analysis of the effect of bipolar electrocoagulation during laparoscopic ovarian endometrioma stripping on ovarian reserve |
11 |
| Long non-coding RNA MALAT1 expression in patients with gestational diabetes mellitus |
11 |
| Cancer of the vagina |
11 |
| Uterine sarcomas |
11 |
| Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects |
10 |
| FIGO (International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long-term Maternal Implications of Pregnancy Complications-Follow-up Considerations |
10 |
| FIGO review of statements on use of synthetic mesh for pelvic organ prolapse and stress urinary incontinence |
10 |
| Cancer in pregnancy |
10 |
| Standardizing the measurement of maternal morbidity: Pilot study results |
9 |
| A new conceptual framework for maternal morbidity |
9 |
| Planning and implementation of a FIGO postpartum intrauterine device initiative in six countries |
9 |
| A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids |
8 |
| Randomized controlled trial of the effect of endometrial injury on implantation and clinical pregnancy rates during the first ICSI cycle |
8 |
| Systematic review and meta-analysis of complementary treatments for women with symptomatic endometriosis |
8 |
| Implementing and expanding safe abortion care: An international comparative case study of six countries |
8 |
| Diagnostic accuracy of serum miR-122 and miR-199a in women with endometriosis |
8 |
| Meta-analysis of the association of maternal smoking and passive smoking during pregnancy with neural tube defects |
8 |
| Systematic review and meta-analysis of adverse pregnancy outcomes after uterine adenomyosis |
7 |
| Neutrophil-to-lymphocyte ratio and platelet indices in pre-eclampsia |
7 |
| An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis |
7 |
| Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya |
7 |
| Role of angiogenic factors in the pathogenesis and management of pre-eclampsia |
7 |
| International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders |
7 |
| An assessment of depression, psychosocial factors, and resilience among women seeking prenatal care at an urban community health center |
7 |
| A framework for healthcare interventions to address maternal morbidity |
7 |
| Placenta accreta spectrum disorder trends in the context of the universal two-child policy in China and the risk of hysterectomy |
6 |
| The International Childbirth Initiative: 12 steps to safe and respectful MotherBaby-Family maternity care |
6 |
| Systematic review of pelvic floor interventions during pregnancy |
6 |
| The impact of proteinuria on maternal and perinatal outcomes among women with pre-eclampsia |
6 |
| A systematic review and meta-analysis of fetal outcomes following the administration of influenza A/H1N1 vaccination during pregnancy |
6 |
| Validation of the WHO Disability Assessment Schedule (WHODAS 2.0) 12-item tool against the 36-item version for measuring functioning and disability associated with pregnancy and history of severe maternal morbidity |
6 |
| Factors influencing the likelihood of acceptance of postpartum intrauterine devices across four countries: India, Nepal, Sri Lanka, and Tanzania |
6 |
| A systematic review and meta-analysis of randomized controlled trials comparing 17-alpha-hydroxyprogesterone caproate versus placebo for the prevention of recurrent preterm birth |
6 |
| Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders |
6 |
| First trimester glycosylated hemoglobin as a predictor of gestational diabetes mellitus |
6 |
| Prevalence of conscientious objection to legal abortion among clinicians in northern Ghana |
6 |
| Role of imaging in the routine management of endometrial cancer |
5 |
| Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment |
5 |
| Evaluating the utility of a point-of-care glucometer for the diagnosis of gestational diabetes |
5 |
| Prospective study of sentinel lymph node mapping for endometrial cancer |
5 |
